Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
Top Cited Papers
- 16 April 2021
- journal article
- review article
- Published by Elsevier BV in Life Sciences
- Vol. 277, 119504
- https://doi.org/10.1016/j.lfs.2021.119504
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India (BT/PR20836/MED/30/1727/2016)
This publication has 223 references indexed in Scilit:
- Failure of Amino Acid Homeostasis Causes Cell Death following Proteasome InhibitionMolecular Cell, 2012
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axisCell Death & Differentiation, 2011
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic LeukemiaJAMA, 2011
- Histone deacetylase inhibitors: Potential in cancer therapyJournal of Cellular Biochemistry, 2009
- Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammalsNature, 2009
- The many roles of histone deacetylases in development and physiology: implications for disease and therapyNature Reviews Genetics, 2009
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004